{
    "organizations": [],
    "uuid": "e2aaf83ae6e6590908efa590174371875b61d8a2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-advances-policy-to-make-develo/brief-fda-advances-policy-to-make-development-of-drugs-diagnostics-in-cancer-trials-more-efficient-idUSFWN1RP0OZ",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Advances Policy To Make Development Of Drugs & Diagnostics In Cancer Trials More Efficient",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - U.S. Food and Drug Administration:\n* FDA ADVANCES POLICY TO MAKE CO-DEVELOPMENT OF DRUGS AND DIAGNOSTICS IN CANCER TRIALS MORE EFFICIENT\n* FDA SAYS IS STREAMLINING AGENCYâ€™S REVIEW OF CANCER DIAGNOSTICS THAT ARE DEVELOPED IN CONJUNCTION WITH DRUG TRIALS\n* ISSUING DRAFT GUIDANCE FOR CERTAIN ONCOLOGY TRIAL SPONSORS WITH OPTIONAL STREAMLINED SUBMISSION PROCESS REGARDING USE OF INVESTIGATIONAL IN VITRO DIAGNOSTIC\n* OPTIONAL SUBMISSION PROCESS DETERMINES WHETHER USE OF IVD IN CANCER TRIALS IS CONSIDERED SIGNIFICANT/NON-SIGNIFICANT RISK OR EXEMPT FROM FURTHER REVIEW Source text: ( bit.ly/2Hw1VYA )\n ",
    "published": "2018-04-13T00:34:00.000+03:00",
    "crawled": "2018-04-13T17:55:55.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "advance",
        "policy",
        "make",
        "drug",
        "diagnostics",
        "cancer",
        "trial",
        "efficient",
        "fda",
        "say",
        "streamlining",
        "agency",
        "review",
        "cancer",
        "diagnostics",
        "developed",
        "conjunction",
        "drug",
        "trial",
        "issuing",
        "draft",
        "guidance",
        "certain",
        "oncology",
        "trial",
        "sponsor",
        "optional",
        "streamlined",
        "submission",
        "process",
        "regarding",
        "use",
        "investigational",
        "vitro",
        "diagnostic",
        "optional",
        "submission",
        "process",
        "determines",
        "whether",
        "use",
        "ivd",
        "cancer",
        "trial",
        "considered",
        "risk",
        "exempt",
        "review",
        "source",
        "text"
    ]
}